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1. Gastric motility and neurotransmitter release in response to vagal stimulation were
studied using a vascularly isolated perfused rat stomach. Gastric motor responses were
recorded by a strain gauge force transducer implanted on the proximal stomach.
2. Electrical stimulation of vagal trunk (0-5-20 Hz) produced a triphasic response which was
composed of a rapid transient relaxation (first phase) followed by a phasic contraction
(second phase) and a delayed prolonged relaxation (third phase). Maximum responses of the
first, second and third phase were observed at 2-5, 5 and 10 Hz, respectively. Intra-arterial
infusion of tetrodotoxin (0-1 /LM) or hexamethonium (100 /M) completely abolished the
triphasic response.
3. The nitric oxide (NO) biosynthesis inhibitor NG-nitro-L-arginine (L-NNA; 100 ZM)
significantly antagonized the rapid relaxation but had no effect on the delayed relaxation,
while vasoactive intestinal polypeptide (VIP) antagonist (1 /M) significantly reduced the
delayed relaxation without affecting the rapid relaxation.
4. In response to vagal stimulation, NO production ([3H]citrulline formation in gastric tissue
preloaded with [3H]arginine) was maximum at 2-5 Hz, whereas VIP release into the venous
effluent was largest at 10 Hz. Hexamethonium abolished vagal-stimulated NO production
and VIP release. L-NNA had no effect on VIP release in response to vagal stimulation.
5. The nicotinic receptor agonist 1,1-dimethyl-4-phenylpiperizinium (DMPP; 100 UM) also
caused a triphasic response similar to that observed with vagal stimulation and produced a
significant increase in VIP and NO formation. DMPP-evoked VIP release was not affected
by L-NNA. Similarly, DMPP-evoked NO production was not antagonized by VIP
antagonist.
6. These results suggest that vagus nerve stimulation evokes NO and VIP release via nicotinic
synapses which cause different modes of relaxation of the stomach. There is no interaction
between NO and VIP release in response to vagal stimulation.
Receptive relaxation allows the stomach to receive large Pharmacological evidence has suggested that at least two
volumes with only minimal increase in pressure during different NANC inhibitory systems are present in the
food intake (Canon & Lieb, 1911). The vagus nerve plays gastrointestinal (GI) tract (Costa, Furness & Humpreys,
an important role in the mediation of receptive relaxation 1986; Manzini, Maggi & Meli, 1986). Vasoactive intestinal
via non-adrenergic, non-cholinergic (NANC) innervation polypeptide (VIP) has been proposed as a likely neuro-
to the stomach (Abrahamsson & Jansson, 1969). However, transmitter of NANC neurons, as VIP immunoreactivity
the nature of the specific neurotransmitter(s) released by is present in intrinsic neurons of the stomach (Larsson,
these NANC neurons responsible for gastric relaxation Fahrenkrug, Schaffalitzky, Sundler, Hakanson & Rehfeld,
remains to be established. 1976; Fahrenkrug, Haglund, Jordal, Lundgren, Olbe &
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Schaffalitzky de Muckadell, 1978). Furthermore, VIP is
released upon nerve depolarization by KCl or electrical
stimulation (Grider & Makhlouf, 1987; Agoston, Conlon &
Whittaker, 1988; Ohta, Itoh & Ohga, 1990) and relaxes
gastric muscle cells with a concomitant increase of intra-
cellular cyclic AMP (Bitar & Makhlouf, 1982). Vagal
stimulation produces a frequency-dependent increase of
VIP released into the portal vein (Yasui et al. 1987; Reid,
Shulkes & Titchen, 1988). Trypsin or VIP antiserum
inhibits a neurally induced relaxation of the stomach
(D'Amato, De Beurme & Lefebvre, 1988; Li & Rand,
1990). These observations support the concept that VIP is
an inhibitory NANC transmitter. However, in other
studies, the VIP antagonist fails to prevent NANC-induced
relaxation (D'Amato et al. 1988; Fisher, Anderson &
Waldron, 1993) and there were no similarities between
gastric relaxation induced by VIP and that induced by
the stimulation of NANC neurons in cat gastric fundus
(D'Amato et at. 1988).
Recently, nitric oxide (NO) has been proposed as an
inhibitory NANC neurotransmitter in the gastrointestinal
tract. Gastric relaxation induced by the stimulation of
NANC nerves was significantly antagonized by the NO
biosynthesis inhibitor NG-nitro-L-arginine (L-NNA) or
NG-nitro-L-arginine methyl ester (L-NAME) in the rat
stomach (Boeckxstaens et at. 1991; D'Amato, Curro &
Montuschi, 1992; Shimamura, Fujisawa, Toda & Sunano,
1993). Exogenously applied NO or sodium nitroprusside,
an activator of soluble guanylate cyclase, produces
relaxation which mimics NANC-induced relaxation in rat
gastric fundus (Boeckxstaens et al. 1991), guinea-pig ileum
(Osthaus & Galligan, 1991) and canine ileocolonic junction
(Bult, Boeckxstaens, Pelckmans, Jordaens, Van Maercke
& Herman, 1990). The presence of NO synthase was
detected in the myenteric plexus (Bredt, Hwang &
Snyder, 1990; Costa et at. 1992; Aimi, Kimura, Kinoshita,
Minami, Fujimura & Vincent, 1993) as well as in the central
nervous system (Bredt et al. 1990). A rapid relaxation of
the stomach in response to vagal stimulation was
inhibited by L-NAME (Lefebvre, De Vriese & Smits,
1992b). The involvement of the NO pathway in adaptive
relaxation of the stomach, mediated by the intramural
myenteric plexus, was recently shown in the isolated
guinea-pig stomach (Desai, Sessa & Vane, 1991). These
observations suggest that NO may be involved in
mediating gastric relaxation.
Grider, Murthy, Jin & Makhlouf (1992) demonstrated that
VIP itself stimulates NO production from isolated guinea-
pig gastric muscle cells; however, the interaction between
NO and VIP release upon vagal stimulation still remains
unclear. The exact roles of NO and VIP in the vagal
mediation of gastric motility have not been fully studied.
Furthermore, there is no direct evidence showing NO is
released from the gastric myenteric plexus upon vagal
Therefore, the aims of this study were (1) to characterize
the role of NO and VIP in the regulation of gastric
relaxation, (2) to investigate the possible mechanism of
NO and VIP release in response to vagal stimulation, and
(3) to clarify the interaction between NO and VIP release
in response to vagal stimulation.
METHODS
Preparation of the isolated perfused stomach
One hundred and twenty-five male Sprague-Dawley rats,
weighing 250-300 g, were anaesthetized with an intramuscular
injection of ketamine hydrochloride (50 mg kg-') after a 24 h
fast. Isolation and vascular perfusion of the stomach were
performed as previously described (Yokotani, Okuma & Osumi,
1991; Schubelt & Makhlouf, 1993). After opening the abdomen
with a mid-line incision, the abdominal aorta was exposed retro-
peritoneally. The coeliac artery was identified and the abdominal
aorta was ligated just above the branching of the coeliac artery; a
cannula was inserted into the coeliac artery. The stomach was
perfused through the coeliac artery with a peristaltic pump
(Harvard Apparatus, South Natick, MA, USA) at a constant flow
rate of 2 ml min-. The perfusate was composed of modified
Krebs-Henseleit bicarbonate (KHB) buffer containing (mM): 118
NaCl, 4.8 KCl, 2-5 CaCl2, 25 NaHCO3, 1-2 KH2PO4, 1P2 MgSO4,
11 1 glucose; and 0 2% bovine serum albumin and 4% dextran.
The perfusate was maintained at pH 7-4 and 37 0C, bubbled with
a mixture of 95% 02 and 5% C02. The oesophagus, duodenum,
spleen and pancreas were dissected after ligation of vessels. The
gastric venous effluent was recovered through a cannula in the
portal vein. Both vagal trunks around the oesophagus were
carefully isolated and cut 1 cm above the lower oesophageal
sphincter. The vascularly perfused stomach was kept in a
chamber prewarmed at 37 0C. Following isolation of the stomach,
rats were killed by an overdose of pentobarbitone given i.v.
(200 mg kg-'). After washing the gastric contents through a
cannula inserted into the stomach lumen via the pylorus ring,
the stomach was slightly distended with 2 ml of saline pre-
warmed to 37 0C. A volume of 2 ml was used because this volume
represents 10-30% of the normal feeding capacity of the
stomach (Schubelt & Makhlouf, 1993), and preliminary
experiments showed that maximal gastric response to a maximal
dose of carbachol (10 #M) was observed with this volume.
Measurement of gastric contraction
Since receptive relaxation mainly involves the proximal stomach
(Wilbur, Kelly & Code, 1974), this study was designed to record
motor responses of the gastric body (proximal stomach) in
response to electrical stimulation of the vagus nerve. Gastric
motility was monitored by a force transducer implanted on the
serosal surface of the mid-portion of the gastric body to detect
circular muscle contraction as previously described (Mizumoto,
Sano, Matsunaga, Yamamoto, Itoh & Oshima, 1993). The lead
wires of transducers were connected to an amplifier (FS-04M;
Star Medical, Tokyo), and the signals from the amplifier were
recorded on a multi-channel, pen-writing recorder (Gould,
Cleveland, OH, USA). Gastric motility was monitored in
response to graded electrical stimulation of the vagus nerve and
studies were repeated in the presence of various antagonists. For
frequency-response studies, different frequencies (0-5-20 Hz)
stimulation.
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were applied in random order.
JNO and VIP in gastric relaxation
Experimental procedures
After an equilibration period of 60 min, bilateral vagus nerves
were electrically stimulated with square-wave pulses (150 pulses
at 0-5-20 Hz frequency, supramaximal voltage of 5 V and 2 ms
duration) using platinum electrodes. The responses to vagal
stimulations were quite reproducible up to 6-8 times when
applied every 20 min. Stimulation was performed every 20 min
and evaluated in triplicate, and the mean value was used to
calculate tension change. To examine possible mediators by which
vagus nerves mediate gastric motility, the following drugs were
used: atropine (muscarinic receptor antagonist), hexamethonium
(nicotinic receptor antagonist), phentolamine (a-antagonist),
propranolol (fl-antagonist), tetrodotoxin (Na+ channel blocker),
NG-nitro-L-arginine (L-NNA; NO biosynthesis inhibitor),
Methylene Blue (a soluble guanylate cyclase inhibitor), a VIP
antagonist devised by a hybrid peptide strategy (Gozes, Meltzer,
Rubinrout, Brenneman & Fridkin, 1989), and trypsin (type
XII-S; peptidase). After intra-arterial infusion of various
antagonists for 15 min, the vagus nerve was stimulated again
and gastric motor activities with and without pretreatment with
antagonists were compared. Only one antagonist was
administered in each stomach preparation.
Measurement of VIP
Effluent from the portal vein was collected every 30 s in chilled
tubes containing bacitracin (20 /M) and aprotinin (1000 u ml-')
before, during and after the vagal stimulation (5 V, 1-10 Hz,
2 ms, 150 pulses) or following the administration of 1,1-dimethyl-
4-phenylpiperizinium (DMPP; 1-100 /SM). Samples were stored
at -20°C for subsequent radioimmunoassay (RIA). RIA of VIP
was performed with rabbit VIP antiserum (Incstar, Stillwater,
MN, USA) as previously described (Wiley, O'Dorisio & Owyang,
1988). Intra-assay and interassay variability were 5 and 8%,
respectively. VIP release was expressed as the percentage change
from basal levels measured in the absence of test agents.
Measurement of NO production
Production of NO was measured in gastric tissue preloaded with
L-[3H]arginine and expressed as amount of L-[3H]citrulline
formed in the tissue as described by Bredt & Snyder (1989).
L-Citrulline and NO are produced in a 1 : 1 ratio from L-arginine
by the action of NO synthase. One hundred and sixty male
Sprague-Dawley rats, weighing 250-300 g, were anaesthetized
with intramuscular injection of ketamine hydrochloride
(50 mg kg-) after a 24 h fast. Whole stomach with attached
vagus nerve was quickly removed and incubated in a 20 ml
organ bath with [3H]arginine (3 1sCi ml-') for 5 min at 37 'C.
Animals were killed by an overdose of pentobarbitone given I.v.
(200 mg kg-). Immediately following vagal stimulation (5 V,
2 ms, 1-10 Hz, 150 pulses) or DMPP administration (1-100 FM
for 1 min), the reaction was stopped by flash freezing gastric
tissues in liquid nitrogen. The samples were stored at -70 'C for
subsequent measurement of L-[3H]citrulline. After removing the
mucosa from the stomach, muscle tissue was homogenized by a
1 ml straight wall grinder (Radnoti Glass Technology, Monrovia,
CA, USA). Following the precipitation of protein with 1 M
trichloroacetic acid, samples were centrifuged at 1800 g for
15 min. The protein content of the pellets was measured by the
Biorad method using bovine serum albumin (Bradford, 1976).
L-[3H]citrulline in the supernatants was extracted with diethyl
ether and an alliquot applied to a Dowex AG50WX-8 column
and eluted with Hepes buffer (pH 6 0). L-[3H]citrulline in the
effluent was measured by liquid scintillation spectroscopy, and
the production of L-citrulline (stoichiometrically equivalent to
NO) was expressed as c.p.m. per milligram protein.
Materials
Atropine, aprotinin, D-arginine, L-arginine, bacitracin, bovine
serum albumin, dextran, 1,1-dimethyl-4-phenylpiperizinium
(DMPP), hexamethonium, phentolamine, propranolol, tetrodo-
toxin and trypsin (type XII-S) were obtained from Sigma
Chemical Co. (St Louis, MO, USA); L-[3Hlarginine from New
England Nuclear (Boston, MA, USA); Dowex AG50W-X8 from
Biorad (Richmond, CA, USA); Methylene Blue from Fisher
Scientific Company (Springfield, NJ, USA); VIP and VIP
antagonist from Bachem (Torrance, CA, USA). NO solutions
were made from 99% NO gas (MG Industries, Valley Forge, PA,
USA). Oxygen was eliminated by bubbling iced KHB buffer with
He for 2 h. A saturated solution of NO (10 /M) was prepared by
injection of 250 A1 of NO gas into 1 ml of the oxygen-free
Krebs-Henseleit buffer as described by Ignarro, Byrns, Buga &
Wood (1987) and dilutions were prepared in vacuum tubes.
Analysis of data
Before the experiment each force transducer was calibrated by
application of known weights (1, 2, 5, 10, 20 and 50 g), according
to a previously described method (Jacoby, Bass & Bennett, 1963).
The calibration curve was linear with 1-50 g weights. Every
contraction or relaxation in response to vagal stimulation was
estimated from the basal (pre-stimulating) levels. The mean
amplitude of contraction or relaxation was determined by
dividing the sum of the amplitudes of each contraction or
relaxation by the number of contractions or relaxations and
expressed in grams. Results were expressed as means + S.E.M. In
the case of the study of the action of antagonists on gastric motor
responses, Student's paired t test was used. In the case of the
antagonists study on VIP and NO releases, Student's t test was
used. P < 0 05 was considered significant.
RESULTS
Mechanical responses to NO, VIP, DMPP and vagal
stimulation
Strain gauge transducers implanted on the serosal surface
of the gastric body enabled us to detect spontaneous phasic
contractions during the resting state in a vascularly
isolated perfused rat stomach. The system gave
reproducible results and responded to known stimulatory
agents (carbachol or substance P) or inhibitory agents
(VIP or NO). Intra-arterial infusion of VIP (1 uM) or NO
(10 fM) for 10 s produced different modes of relaxation.
VIP (1 uM) caused a delayed prolonged relaxation,
whereas NO (10 /M) provoked a rapid transient
relaxation (Fig. 1). VIP-evoked relaxation was not
affected by L-NNA (100 SM). NO-induced relaxation was
not affected by VIP antagonist (1 um; data not shown).
As shown in Fig. 2, electrical stimulation (5 V, 2 ms, 5 Hz,
150 pulses) of the vagal trunk produced a triphasic
response which was composed of a rapid transient
relaxation (first phase) followed by a phasic contraction
(second phase) and a delayed prolonged relaxation (third
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B
5g
NO 1 min
Figure 1
Relaxation of isolated vascularly perfused rat
1 /M VIP (A) and 10/SM nitric oxide (NO; B)
phase). Rapid relaxation was observed during vagal
stimulation with various frequencies and phasic contraction
was observed after the cessation of vagal stimulation
('off contraction'). Following phasic contraction, delayed
prolonged relaxation was observed which gradually
returned to basal level in 1-3 min. In 125 preparations
tested, these triphasic responses to vagal stimulation
(5 Hz) were observed in 103 preparations (82'4%). In
eighteen preparations (14-4%) we did not observe the
third phase and in four preparations (3 2 %) the first phase
was not observed. The preparations which showed
triphasic response were used for further studies with
A
stomach evoked by intra-arterial infusion of
antagonists. Administration of phentolamine (1 uM) or
propranolol (1 /,M) had no effect on these triphasic
responses (data not shown). Intra-arterial infusion of
Ca2"-free medium containing 1 mm EDTA, which slightly
decreased the basal tone (Fig. 2A), completely abolished
the triphasic response (Fig. 2A). Similarly, intra-arterial
infusion of tetrodotoxin (0 1 /SM) for 15 min (total dose,
0-96 jug) abolished the triphasic response without affecting
the basal tone (Fig. 2B); and administration of hexa-
methonium (100 /SM) for 15 min (total dose, 1P09 mg) also
abolished the triphasic response to vagal stimulation
without affecting the basal tone (Fig. 2C).
2nd phase
1 st phase
3rd phase
Vs Vs
Ca2+ free
B
Vs Vs
Tetrodotoxin
C
Vs
Vs
5 g
1 min
Hexamethonium
Figure 2. Effects of intra-arterial infusion of Ca2"-free medium, tetrodotoxin, or
hexamethonium on the triphasic response to vagal stimulation
Vagal stimulation (VS): 5 V, 5 Hz frequency, 150 pulses, 2 ms duration. Intra-arterial infusion of Ca2+-
free medium (A), tetrodotoxin (1 um; B) or hexamethonium (100 1m; C) completely abolished the
triphasic response to vagal stimulation.
484
A
J. Physiol. 484.2
VIP
JNO and VIP in gastric relaxation
The three phases of contractile response to vagal
stimulation were frequency dependent. Rapid relaxation
was most pronounced during lower frequencies of
stimulation (0-5-2-5 Hz), whereas the delayed prolonged
relaxation was observed mostly during higher frequencies
of stimulation (5-20 Hz). Maximum relaxation of the first
phase, estimated from the frequency-response curve, was
observed at 2-5 Hz frequency, whereas maximum
relaxation of the third phase was observed at 10 Hz.
Maximum contraction of the second phase occurred at
5 Hz (Fig. 3).
To investigate the role of NO in the regulation of gastric
relaxation, we examined the effects of L-NNA, a NO
biosynthesis inhibitor. Boeckxstaens et al. (1991) found
that L-NMMA and L-NNA increased the basal muscle
tension of the canine gastric fundus and suggested that
tonic release of NO may regulate basal tone in the
proximal stomach. In our experiments using a vascularly
perfused rat stomach, a transient, small increase of basal
tension (0 35 + 0 1 g, n = 3) was observed following the
administration of L-NNA (100 uM) in three of eight
preparations tested. A 15 min infusion of L-NNA
(100 #m; total dose, 0X66 mg) markedly antagonized the
first phase of relaxation (by 95 + 3%) and enhanced the
second phase of contraction (by 55 + 15%) in response to
vagal stimulation (5 Hz; P < 0 01, n = 8; Fig. 4A). In the
presence of L-NNA (100 uM), a rapid relaxation was
almost completely abolished and a phasic contraction was
observed immediately after the start of vagal stimulation.
L-NNA had no effect on the third phase of relaxation
(Fig. 4A). The effect of L-NNA was prevented by the pre-
administration of L-arginine (1 mM; total dose, 5-1 mg;
Fig. 5A) but not by D-arginine (1 mM; data not shown).
Similarly, Methylene Blue (50 #m; total dose, 561 ug), an
inhibitor of soluble guanylate cyclase, also completely
antagonized the first phase of relaxation and enhanced
the second phase of contraction (Fig. 4B).
To investigate whether the contractile response to vagal
stimulation is mediated via the cholinergic pathway, we
examined the effects of atropine. Atropine (0-1 /zm; total
dose, 2-03 ,ug), which had no effect on the basal tone,
markedly reduced the second phase of contraction in
response to vagal stimulation (5 Hz; P < 0 01, n = 8).
However, relaxation of neither the first phase nor the
third phase was affected by pretreatment with atropine
(0- 1 um; Figs 4C and 5B).
To investigate the role of VIP in gastric relaxation, we
examined the effects of VIP antagonist. VIP antagonist
(1 /zm; total dose, 103 ug) reduced by 55 + 7% the
amplitude of relaxation evoked by exogenously applied
VIP (1 /tM; P < 0-01, n = 8) but had no action on that
A
1 2-5 5 10 20 Hz 1 min
B
+5 -
0)
0)L-
o
0-
0-5
2nd phase
1 st phase
3rd phase ,
1 2-5 5
Frequency (Hz)
10 20
Figure 3. Gastric motor responses to vagal stimulation
A, typical tracings of gastric motor responses to vagal stimulation (VS; 5 V, 2 ms duration, 150 pulses)
at various frequencies (1-20 Hz). B, gastric contraction or relaxation in response to different frequencies
of vagal stimulation (0'5-20 Hz). A rapid relaxation (1st phase) was observed at lower frequencies
(0 5-1 Hz), while a delayed prolonged relaxation (3rd phase) was observed at higher frequencies
(5-10 Hz). Maximum contractions of the second phase occured at 5 Hz. Means + S.E.M., n = 8.
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evoked by NO (10 uM). VIP antagonist (1 FM) also
markedly reduced the amplitude of the third phase of
prolonged relaxation in response to vagal stimulation
(5Hz) without affecting the first and second phases
(P < 0O01, n = 8; Figs 4D and 5C). The duration of the
third phase of delayed relaxation was also significantly
reduced by VIP antagonist from 1P8 + 0'3 to 1P1 + 0-2 min
(P < 0 05, n = 8) and as a result the motility index of the
third phase was reduced by 76 + 12% (P < 0105, n = 8).
Similar results were obtained by pretreatment with
trypsin (3 gM; total dose, 2416 mg; Fig. 4E).
Intra-arterial infusion of DMPP at 1 km! produced a
modest inhibition of the ongoing phasic activity. DMPP at
10/UM produced a biphasic response characterized by a
rapid transient relaxation followed by a phasic
contraction (Fig. 6). At a higher concentration, DMPP
(100 fm) caused a triphasic response, which was composed
of a rapid transient relaxation followed by a phasic
contraction and delayed prolonged relaxation, similar to
that observed with electrical vagal stimulation (Fig. 6).
The delayed prolonged relaxation was only observed with
a higher concentration ofDMPP (100/4m).
NO production and VIP release in response to vagal
stimulation
To confirm the role of NO and VIP in the mediation of
gastric relaxation, we examined NO production and VIP
release in response to vagal stimulation with different
frequencies. Basal level of [3H]citrulline (NO production)
was 256 ± 34 c.p.m. (mg proteinft. Vagal stimulation
produced a significant increase of tissue [3H]citrulline,
with maximum production observed at 2'5 Hz
(122 + 39% increase over basal). There was no further
increase of [3H]citrulline in response to vagal stimulation
at 5 or 10 Hz (Fig. 7). Pretreatment with hexamethonium
A
L-NNA
Vs VS
Methylene Blue
Vs VS
VS
Figure 4. Studies to determine the mediators of the
triphasic response to vagal stimulation
Representative tracings to demonstrate the effects of L-NNA
(100/4m; A), Methylene Blue (50/um; B), atropine
(0'1 /4km; C), VIP antagonist (1 /m; D)and trypsin (3/m; E)
on the triphasic response to vagal stimulation (VS; 5 V, 5 Hz,
150 pulses, 2 ms duration). L-NNA (A) or Methylene Blue (B)
significantly antagonized the first phase of relaxation, while
VIP antagonist (D) or trypsin (E) significantly reduced the
third phase ofprolonged relaxation.
Atropine
Vs
VIP antagonist
VS VS
Trypsin 5 g
Vs Vs
mi
B
C
D
E
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NO and VIP in gastric relaxation
o Control
0 L-NNA
* L-NNA + L-Arg
1st phase 2nd phase 3rd phase
Figure 5. Effects of L-NNA, atropine and VIP
antagonist on the triphasic response to vagal
stimulation (5 V, 2 ms, 5 Hz)
L-NNA (100 /M; A), atropine (0 1 FM; B)and VIP
antagonist (1 FuM; C) significantly antagonized the first
phase of relaxation, the second phase of contraction and
the third phase of prolonged relaxation, respectively, in
response to vagal stimulation. Means + S.E.M., n = 8,
** P< 0'01.
B
a)
0
o
IL
C
El Control
E Atropine
1 st phase 2nd phase 3rd phase
O Control
0 VIP antagonist
1 st phase 2nd phase 3rd phase
(100 uM) for 15 min completely abolished the NO increase
in response to vagal stimulation (2'5 Hz; Table 1).
Furthermore, L-NNA (100 ,UM) and Ca2+-free medium
completely abolished the increase of [3H]citrulline in
response to vagal stimulation (2'5 Hz; Table 1).
The basal VIP concentration in the venous effluent was
66 + 12 pg ml-'. Significant increases were observed
immediately following vagal stimulation. On terminating
the stimulation, VIP levels rapidly decreased to basal
levels within 2 min. VIP responses to vagal stimulation
increased in a frequency-dependent manner and the
largest increase was observed at 10 Hz, which produced a
1 aM DMPP 10/M DMPP
74 + 16% increase over the basal level (Fig. 7). Pre-
treatment with hexamethonium (100 /SM) or Ca2+-free
medium for 15 min abolished VIP increase in response to
vagal stimulation (10 Hz; Table 1). In contrast, L-NNA
(100,uM) failed to prevent VIP increase in response to
vagal stimulation (10 Hz; Table 1).
VIP release and NO production in response to
DMPP
We next studied the effects of DMPP on NO production
and VIP release. DMPP (1-100 saM) significantly increased
[3H]citrulline and VIP release in a dose-dependent
manner. The largest effects were observed at 100,uM
2nd phase
1 st phase |D3rd phase
5 g
100.FM DMPP 1 min
Figure 6. Typical tracings of gastric motor responses to intra-arterial infusion of DMPP,
a nicotinic receptor agonist
The motility response to DMPP (1-100 FSM) appears to be dose dependent (see text).
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Table 1. Vagal stimulation-evoked NO production and VIP release from the rat stomach
NO production (%) VIP release (%)
Control 122 + 39 74 + 12
Ca2+- free medium 8 + 5** 4+ 3**
Hexamethonium (100/M) 12 + 8** 7 + 5**
Tetrodotoxin (0-1 SM) 8 + 6** 5 + 4**
L-NNA (100/M) 6 + 4** 72 + 15
Vagal stimulation (5 V, 2 ms, 150 pulses) was applied at 2-5 Hz for NO assay and 10 Hz for VIP asay
to obtain maximal responses. Data are expressed as percentage increase over basal levels.
Means +S.E.M., n =6, ** P < 001.
DMPP, which produced a 175 + 32% increase of
[3H]citrulline over the basal level and 120 + 24% increase
of VIP over the basal level, respectively (Fig. 8). The
DMPP (100 /uM)-evoked increase in [3H]citrulline was
completely abolished by L-NNA (100 /M) or tetrodotoxin
(0'1 /SM). On the other hand, VIP antagonist (1 /SM) had no
effect on DMPP-evoked [3H]citrulline increase. DMPP-
evoked VIP release was not affected by L-NNA (Table 2).
DISCUSSION
In this study, we demonstrated that both nitric oxide and
VIP are involved in the vagal regulation of gastric
relaxation. Electrical stimulation (5 V, 2 ms, 5 Hz, 150
pulses) of the vagal trunk produced a triphasic response
which was composed of a rapid transient relaxation (first
phase) followed by a phasic contraction (second phase) and
a delayed prolonged relaxation (third phase). Intra-
arterial infusion of a Ca2+-free medium containing 1 mM
EDTA or tetrodotoxin completely abolished these
responses, suggesting the involvement of neural
mechanisms. Our studies also demonstrated that electrical
vagal stimulation resulted in both gastric relaxation and
contraction but optimal responses occurred at different
frequencies, suggesting that these responses are mediated
via different neural pathways and neurotransmitters.
Triphasic responses to electrical nerve stimulation in the
rat stomach have been shown both in vitro (Ito, Kimura &
Ohga, 1988) and in vivo (Lefebvre, Baert & Barbier,
1992a; Baccari, Calamai & Staderini, 1992). Ito et al.
1 50
NO
0
(0 100 -d
CD
c9 50 I
(1988) showed a triphasic response using circular muscle
strips obtained from embryonic rat stomach. Consistent
with our results, they showed that the first phase of rapid
relaxation, the second phase of contraction and the third
phase of delayed relaxation were at a maximum at 2, 5
and 10 Hz, respectively. Lefebvre et al. (1992a) reported
that vagal stimulation produced a triphasic response
which was composed of a rapid relaxation, followed by a
rebound contraction and a delayed relaxation. As L-NNA
significantly antagonized the rapid relaxation and
enhanced the contraction without affecting the delayed
relaxation, and as atropine inhibited the rebound
contraction, the authors proposed that the first phase of
relaxation and the second phase of contraction were
mediated by NO and acetylcholine, respectively. However,
the mechanism for the third phase of delayed relaxation
was not addressed.
To confirm the role of NO in the regulation of gastric
relaxation, we examined the effects of L-NNA, a nitric
oxide biosynthesis inhibitor. L-NNA (100 AM) significantly
antagonized the first phase of relaxation in response to
vagal stimulation. The inhibitory effect ofL-NNA (100 /FM)
was significantly prevented by the pre-administration of
L-arginine (1 mM) but not by D-arginine (1 mM). These
observations indicate that the rapid relaxation in
response to vagal stimulation was mediated by the release
of NO. Methylene Blue has been reported to be a selective
inhibitor of soluble guanylate cyclase, the proposed site of
action ofNO (Ward et al. 1992; Chakder & Rattan, 1993).
Figure 7. NO production and VIP release in response
to vagal stimulation
Vagal stimulation: 5 V, 2 ms duration, 150 pulses, 1-10 Hz.
The maximal NO production was observed at 2-5 Hz, while
VIP release was the largest at 10 Hz, suggesting differential
release ofNO and VIP during vagal stimulation.
Means + S.E.M., n= 6.
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Table 2. DMPP-induced NO production (['H]citrulline) and VIP release from the rat stomach
NO production (%) VIP release (%)
Control 175 + 32 120 + 24
Hexamethonium (100 uM) 5 + 4** 7 + 5**
Tetrodotoxin (01 FuM) 11 + 5** 13 + 10**
L-NNA (100/tM) 7+4** 126 + 31
VIP antagonist (1 uM) 156 + 45 n.t.
Data are expressed as percentage increase over basal levels. n.t., not tested. Means + S.E.M., n = 6,
**P<0.01.
Similar to L-NNA, Methylene Blue (50 uM) completely
antagonized the first phase of relaxation and enhanced
the second phase of contraction. This further
demonstrated that the observed motor effects of vagal
stimulation involved generation of NO in the gastric wall.
The second phase of contraction in response to vagal
stimulation was significantly antagonized by atropine,
suggesting mediation by acetylcholine release from the
gastric myenteric plexus. However, atropine did not cause
complete inhibition of the second phase of contraction.
This suggests the possible participation of other neuro-
transmitter(s) besides acetylcholine. Baccari et al. (1992)
demonstrated that in the atropine- and guanethidine-
treated animals, vagally mediated rebound contraction
was depressed by prostaglandin synthesis inhibitors. As
the PGE2-evoked excitatory motor responses closely
mimicked the vagally induced rebound contraction, these
investigators proposed that PGE2 may be involved in
mediating the post-stimulus excitatory contraction.
The second phase of phasic contraction was significantly
enhanced by L-NNA, suggesting a neuromodulatory role
of NO on excitatory neurotransmission, as previously
reported by Gustafsson, Wiklund, Wiklund, Persson &
Moncada (1990). They proposed the possibility that the
potentiation of excitatory response to transmural
stimulation by NO biosynthesis inhibitor may be due to
the inhibitory action of endogenous NO on the release of
substance P (Gustafsson et al. 1990) or acetylcholine
(Lefebvre et al. 1992b).
Figure 8. Effects of DMPP on NO production
([3H]citrulline) and VIP release from the rat stomach
DMPP (1-100 FM) caused a dose-dependent increase of
VIP release and NO production, suggesting that VIP and
NO releases were mediated by nicotinic synapses.
Means +S.E.M., n = 6.
As shown in Fig. 1, intra-arterial infusion of NO and VIP
produced different patterns of relaxation in vascularly
isolated perfused rat stomach. VIP caused delayed,
prolonged relaxation, whereas NO produced rapid
transient relaxation. This observation led us to hypothesize
that released NO and VIP during vagal stimulation
provoke distinct different modes of gastric relaxation.
Thus, we next investigated the role of VIP in gastric
relaxation using a novel VIP antagonist. VIP antagonist
(1 /SM) significantly reduced the third phase of prolonged
relaxation without affecting the first and second phase.
Similar results were obtained by the pretreatment of
trypsin (3 uM). Therefore, the delayed prolonged relaxation
was, at least in part, mediated by VIP release. As VIP
antagonist or trypsin did not completely abolish the third
phase of relaxation, we cannot exclude the possibility that
another peptidergic or non-peptidergic neurotransmitter
is released upon vagal stimulation to mediate the delayed,
prolonged relaxation. Besides NO and VIP, adenosine
triphosphate (ATP) has been suggested to be a candidate
of the NANC neurotransmitter in the GI tract (Baccari,
Calamai & Staderini, 1990; Crist, He & Goyal, 1992; Keef,
Du, Ward, McGregor & Sanders, 1993). Further study is
needed to clarify the participation of ATP release in the
mediation of the delayed relaxation in response to vagal
stimulation in rat stomach.
The frequency-dependent release of various neuro-
transmitters in response to nerve stimulation has been
suggested by several authors. Low frequency (2-5 Hz)
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stimulation of the myenteric nerve selectively depleted
ACh release, whereas higher frequency (10-50 Hz) mainly
stimulated VIP release in the guinea-pig myenteric
plexus-longitudinal muscle preparation (Agoston et al.
1988). Yokotani et al. recently demonstrated that
maximum release of ACh and noradrenaline in response
to vagal stimulation was observed at 5 (Yokotani, Okuma,
Nakamura & Osumi, 1993) and 10 Hz (Yokotani et al.
1991), respectively, in the rat stomach. The relaxation of
rat fundic strips evoked by transmural stimulation at
lower frequencies was completely abolished by L-NMMA,
while responses to higher frequencies of stimulation
(> 5 Hz) were only partially reduced by L-NMMA (Li &
Rand, 1990). In contrast, trypsin only reduced relaxation
induced by high frequencies of stimulation, suggesting
that the relaxation in the rat gastric fundus in response to
low frequencies of stimulation was mediated mainly by
NO, whereas peptidergic neurotransmitter(s) was released
at higher frequencies (Boeckxstaens, Pelckmans, De Man,
Bult, Herman & Van Maercke, 1992). We have confirmed
and extended these observations by clearly demonstrating
that the vagal release of NO and VIP are frequency
dependent. In our present study, vagal stimulation
provoked a significant increase of NO production in the
stomach, and maximum effect was observed at 2-5 Hz. On
the other hand, VIP release in response to vagal
stimulation was greatest at 10 Hz.
Grundy, Gharib-Naseri & Hutson (1993) demonstrated
that in the anaesthetized ferret, vagal stimulation (1, 2
and 5 Hz) produced two components of relaxation, an
initial rapid relaxation followed by a slower relaxation.
Similarly to our results, they also showed that
administration of L-NAME significantly reduced the
initial rapid relaxation without affecting the slower
relaxation, whereas VIP immunization only antagonized
the slower relaxation in response to vagal stimulation
(1 Hz). However, the possible interaction between NO and
VIP release in response to vagal stimulation still remains
unclear. We found that there was no interaction between
the release ofNO and VIP following vagal stimulation.
It is not known if NO is the final neurotransmitter
mediating rapid phasic relaxation, or if it serves as a
neuromodulatory substance that facilitates the release of
another NANC neurotransmitter. Previous studies
demonstrate that NO can stimulate VIP release from the
isolated myenteric plexus of the guinea-pig ileum (Grider
& Jin, 1993), suggesting a possible presynaptic
stimulatory action ofNO on VIP release. However, in our
studies, L-NNA had no effect on vagally stimulated VIP
release, and NO-induced relaxation was not antagonized
by VIP antagonist in a vascularly isolated perfused rat
stomach. Therefore, it does not appear that the action of
NO is mediated by VIP in the rat stomach. It is also
important to determine whether NO is released primarily
or secondarily by another NANC neurotransmitter
following vagal stimulation. Grider, Murthy, Jin &
Makhlouf (1992) demonstrated that VIP itself is capable
of stimulating NO production from isolated guinea-pig
gastric muscle cells devoid of neural elements. However,
in our studies, VIP-induced gastric relaxation was not
antagonized by L-NNA. This suggests that the action of
VIP is not mediated by NO in the rat stomach. In
addition, we demonstrated that DMPP-induced NO
production was not affected by VIP antagonist, further
supporting the proposal that NO production is not
mediated by VIP.
Bult et al. (1990) reported that DMPP caused tetrodotoxin-
sensitive relaxation in the canine ileocolonic junction, and
Desai et al. demonstrated that activation of nicotinic
receptors produced relaxation of the guinea-pig stomach,
which was inhibited by L-NMMA (Desai et al. 1991). These
data suggest that stimulation of nicotinic receptors on
postganglionic neurons is responsible for the activation of
the inhibitory neurons which release NO within the gut
wall. The administration of hexamethonium also
abolished the triphasic responses to vagal stimulation,
indicating that all three phases of gastric responses were
mediated by nicotinic synapses. This possibility was
confirmed by the observation that exogenously applied
DMPP (100 /M), a nicotinic receptor agonist, also caused a
triphasic response as shown in Fig. 6. We showed that
DMPP (1-100,UM) significantly increased both NO and
VIP production in a dose-dependent manner. These
observations confirmed that vagal stimulation of NO and
VIP release was mediated by nicotinic synapses.
In summary, we have shown that there is differential
release of NO and VIP depending on the frequency of
electrical vagal stimulation and that there are no
interactions between NO and VIP release upon vagal
stimulation. Through nicotinic synapses, the preganglionic
fibres in the vagal trunk are connected to at least three
different types of postganglionic neurons which contain
acetylcholine, NO and VIP and these serve as neuro-
transmitters to mediate gastric contraction and different
modes of relaxation.
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